Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancers is Scopus-indexed (Q1, CiteScore 9), WoS SCIE. Published by Multidisciplinary Digital Publishing Institute (MDPI).
Checked against the index lists dated .
ISSN 2072-6694Verify ISSN ↗
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Cost to publish: About US$3,499 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 67 / 428 | 84th | Q1 |
| Cancer Research | 58 / 233 | 75th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2009–present, best quartile Q1, CiteScore 9.
Cancers is Q1 in Oncology (rank 67 of 428) and Q1 in Cancer Research (rank 58 of 233), by CiteScore 2025.
Cancers is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 9, which places it in quartile Q1 at the 84th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.410, quartile Q1, with an H-index of 182.
The publisher lists an article processing charge of about US$3,499 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Cancers is published by Multidisciplinary Digital Publishing Institute (MDPI). Its ISSN is 2072-6694.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal per Scopus.
Cancers has an h-index of 224 and a 2-year mean of 5.2 citations per paper (OpenAlex). Its Scopus CiteScore is 9, quartile Q1. On 2-year citations it ranks #54 of 424 Scopus journals in Oncology.
Cancers published 4,092 papers in 2025; its busiest recent year was 2021 with 6,491. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2026), authors are most often from United States (22.9%), Italy (10%) and China (8.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 42 retracted papers are recorded (1.1 per 1,000 papers). The Problematic Paper Screener flags 6 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.